(Q38154014)

29 August 2017

Human papillomaviruses in urological malignancies: a critical assessment (English)

1 reference

29 August 2017

4

Markus Hohenfellner

1 reference

29 August 2017

Boris Hadaschik

2

0 references

Sascha Pahernik

series ordinal

3

object named as

Sascha Pahernik

1 reference

29 August 2017

1

Yanis Tolstov

1 reference

29 August 2017

5

Stefan Duensing

1 reference

29 August 2017

17 October 2013

1 reference

29 August 2017

1 reference

29 August 2017

32

1 reference

29 August 2017

1

1 reference

29 August 2017

46.e19-27

1 reference

Papillomaviruses and cancer: from basic studies to clinical application

29 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Host and viral factors in relation to clearance of human papillomavirus infection: a cohort study in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Papillomaviruses in the causation of human cancers - a brief historical account

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Epidemiologic classification of human papillomavirus types associated with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Cancer associated human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Human papillomavirus immortalization and transformation functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Prospects for new human papillomavirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Non-random integration of the HPV genome in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Human papillomavirus infection and bladder cancer risk: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Molecular diagnosis of human papillomavirus (HPV) infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

The serological response to papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Why do viruses cause cancer? Highlights of the first century of human tumour virology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Sexual behavior and evidence for an infectious cause of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Specific cytogenetic aberrations in two novel human prostatic cell lines immortalized by human papillomavirus type 18 DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Detection of Human Papillomavirus in the Prostate by Polymerase Chain Reaction and in Situ Hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

High Prevalence of Human Papillomavirus in Prostate Tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

HPV persistence and its oncogenic role in prostate tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Human Papillomavirus Types 16 and 18 are not Involved in Human Prostate Carcinogenesis: Analysis of Archival Human Prostate Cancer Specimens by Differential Polymerase Chain Reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Sexual behaviour, STDs and risks for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Penile cancer: epidemiology, pathogenesis and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Mortality of wives of men dying with cancer of the penis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Human papillomavirus, lichen sclerosus and penile cancer: a study in Belgium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Identification and genotyping of human papillomavirus in a Spanish cohort of penile squamous cell carcinomas: correlation with pathologic subtypes, p16(INK4a) expression, and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Prevalence of human papillomavirus and Epstein-Barr virus DNA in penile cancer cases from Brazil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

7 January 2021

Human papillomaviruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Human papillomavirus prevalence and type distribution in penile carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

The Strong Protective Effect of Circumcision against Cancer of the Penis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Male circumcision is associated with a lower prevalence of human papillomavirus-associated penile lesions among Kenyan men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Male circumcision reduces penile high-risk human papillomavirus viral load in a randomised clinical trial in Rakai, Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Male circumcision decreases high-risk human papillomavirus viral load in female partners: a randomized trial in Rakai, Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

The global burden of urinary bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: an evaluation by polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Low frequency of human papillomavirus infection in initial papillary bladder tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Urinary human polyomavirus and papillomavirus infection and bladder cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Human papillomavirus sequences are not detectable by Southern blotting or general primer-mediated polymerase chain reaction in transitional cell tumours of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Human Papillomavirus DNA and P16INK4A are not detected in renal tumors with immunohistochemistry and signal-amplified in situ hybridization in paraffin-embedded tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Human papilloma virus infection and cervical intraepithelial neoplasia in transplanted patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

A survey of human papillomavirus 16 antibodies in patients with epithelial cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

High prevalence of anal squamous intraepithelial lesions and squamous-cell carcinoma in men who have sex with men as seen in a surgical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Autoclave sterilization of instruments used on women with cervical neoplasia is an effective method of eradicating residual human papillomavirus DNA: a polymerase chain reaction-based evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Estimating the long-term effects of HPV vaccination in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

Very high incidence of germ cell tumorigenesis (seminomagenesis) in human papillomavirus type 16 transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLONC.2013.06.012

1 reference

29 August 2017

1 reference

PubMed ID

24140249